FMP
NASDAQ
1.98 USD
-0.07 (-3.54%)
Dr. Vered Bisker-Leib M.D., MBA, Ph.D.
Healthcare
Biotechnology
https://www.compasstherapeutics.com
NASDAQ
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137. Its product candidates also comprise CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1. The company was founded in 2014 and is headquartered in Boston, Massachu...
0001738021
US20454B1044
20454B104
80 Guest Street
617 500 8099
US
26
Apr 5, 2021
0001738021
NASDAQ
Biotechnology
Healthcare
20454B104
US20454B1044
US
1.98
0.57
508.3k
252.42M
-
1.15-3.62
0.3
-
-
-
-
-6
-
https://www.compasstherapeutics.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.